LNG Energy Group Announces Additional Shareholder Alignment Initiatives
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — LNG Energy Group Corp. (TSXV: LNGE) (TSXV: LNGE.WT) (OTCQB: LNGNF) (FRA: 6MH) (the […]
Azincourt Energy Corp. Closes Second Tranche of Private Placement
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, […]
Hampton Financial Corporation Announces 4th Quarter and Full Year Results for 2023
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) […]
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing […]
BlueRush Inc. Releases Fiscal Q1 2024 Results
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — BlueRush Inc. (“BlueRush” or the “Company“) (TSXV:BTV; OTCQB:BTVRF), a pioneering personalized video Software […]
Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), […]
Meiwu Technology Co., Limited Reports Unaudited Financial Results for the First Half Fiscal Year of 2023
Shenzhen, China, Dec. 29, 2023 (GLOBE NEWSWIRE) — Meiwu Technology Co., Limited (NASDAQ: WNW) (“Meiwu” or the “Company”), an online […]
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA […]
TSX News -
Western Forest Products Inc. Announces Release Date of Fourth Quarter and Fiscal 2023 Results and Conference Call Details
VANCOUVER, British Columbia, Dec. 29, 2023 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) fourth […]
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Dec. 29, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics […]
